By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Principia Biopharma 

400 East Jamie Court
Suite 302
South San Francisco   California  94080  U.S.A.
Phone: 650-416-7700 Fax:


SEARCH JOBS








Company News
Principia Biopharma Presents Full Phase 1 Clinical Trial Results For PRN1008, A Novel Reversible Covalent BTK Inhibitor, Supporting Further Clinical Development In Autoimmune And Inflammatory Diseases 6/15/2015 10:58:54 AM
Principia Biopharma And University of California, San Francisco (UCSF) Scientists Announce Publication Of Seminal Paper On Reversible Covalent Drugs In Nature Chemical Biology 5/26/2015 8:30:18 AM
Principia Biopharma Appoints Roy Hardiman As Chief Business Officer And Lewis Shuster To Board Of Directors 1/12/2015 10:27:43 AM
Principia Biopharma Successfully Completes Phase 1 Clinical Trial Of PRN1008, A Novel Oral BTK Inhibitor For Autoimmune Diseases 1/8/2015 11:25:56 AM
Bay Area's Principia Biopharma Secures $50 Million Series B Financing 4/22/2014 6:48:57 AM
Principia Biopharma Expands Executive Management Team 2/13/2014 10:09:16 AM
Principia Biopharma Secures $12.5M Second Tranche in Series A Financing, Expands Senior Management Team 10/29/2012 7:27:00 AM
//-->